Cargando…
Role of epigenetics-microRNA axis in drug resistance of multiple myeloma
Despite administration of novel therapies, multiple myeloma (MM) remains incurable with resistance to drugs leading to relapse in most patients. Thus, it is critical to understand the detailed mechanisms underlying the drug resistance of MM and develop more effective therapeutic strategies. Genetic...
Autores principales: | Rastgoo, Nasrin, Abdi, Jahangir, Hou, Jian, Chang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474298/ https://www.ncbi.nlm.nih.gov/pubmed/28623912 http://dx.doi.org/10.1186/s13045-017-0492-1 |
Ejemplares similares
-
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
por: Abdi, Jahangir, et al.
Publicado: (2017) -
Role of micro-RNAs in drug resistance of multiple myeloma
por: Abdi, Jahangir, et al.
Publicado: (2016) -
Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells
por: Abdi, Jahangir, et al.
Publicado: (2019) -
Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms
por: Abdi, Jahangir, et al.
Publicado: (2013) -
Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms
por: Abdi, Jahangir, et al.
Publicado: (2013)